NovaBay Pharmaceuticals, Inc. Ending Cash

Ending Cash of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Ending Cash growth rates and interactive chart.


Highlights and Quick Summary

  • Ending Cash for the quarter ending June 30, 2022 was $-1.71 Million (a -129.47% decrease compared to previous quarter)
  • Year-over-year quarterly Ending Cash increased by 34.83%
  • Annual Ending Cash for 2021 was $7.98 Million (a -35.79% decrease from previous year)
  • Annual Ending Cash for 2020 was $12.4 Million (a 67.66% increase from previous year)
  • Annual Ending Cash for 2019 was $7.41 Million (a 102.62% increase from previous year)
  • Twelve month Ending Cash ending June 30, 2022 was $1.3 Million (a -53.53% decrease compared to previous quarter)
  • Twelve month trailing Ending Cash decreased by -83.88% year-over-year
Trailing Ending Cash for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$1.3 Million $2.79 Million $7.98 Million $8.04 Million
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Ending Cash of NovaBay Pharmaceuticals, Inc.

Most recent Ending Cashof NBY including historical data for past 10 years.

Interactive Chart of Ending Cash of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Ending Cash for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-1.71 $5.79
2021 $-1.52 $-1.27 $-0.21 $10.98 $7.98
2020 $-1.46 $4.64 $3.07 $6.18 $12.43
2019 $-2.08 $5.35 $0.74 $3.41 $7.41
2018 $-2.02 $-1.63 $-1.5 $8.81 $3.66
2017 $-2.88 $0.35 $-1.68 $7.87 $3.67
2016 $0.56 $5.94 $2.07 $1.43 $9.99
2015 $-1.0 $-3.83 $1.61 $5.6 $2.39
2014 $-2.46 $0.13 $-2.56 $10.32 $5.43
2013 $3.57 $0.34 $-1.79 $8.39 $10.5
2012 $5.52 $2.57 $-1.47 $6.12 $12.74
2011 $-4.0 $8.43

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology